For the fashion world, the Covid-19 scale has been no less than unprecedented. Currently, only supportive care through drug reuse is the most feasible technique for dealing with the situation, pharma Excellence eSummit experts organized through HEAL Health Connect Solutions said, according to HealthScape on August 20.
Drug reuse is the use of an approved drug for the remedy of a disease or condition other than that for which it was approved.
Experts say that drug reuse can temporarily take on the disease, since those drugs are approved, commercially available, safe for humans, and their side effects are well known. Medicines reuse has the potential to breathe new life into the health and pharmacy sector in India.
The expert panel speculated that India will play a vital role in repurposing drugs for the Covid-19 vaccine source chain around the world.
Speaking of the demanding situations the pharmaceutical industry faced during the closure and its transition to virtual adoption, Sudarshan Jain, general secretary of the Indian Pharmaceutical Alliance (IPA), said in a statement: “Covid-19 raised the greatest humanitarian challenge. However, in this time of crisis, the fitness industry and pharmacy has played a vital role ».
He added that India has been at the forefront in drug reuse as it has a component in the supply of drugs to the world. India plays a role in maintaining the global supply chain. The Indian pharmaceutical industry is ready not only for “Make in India” but also “Make for the World”.
He believes that the Indian pharmaceutical industry is on the verge of primary change. India accounts for 50% of the world’s vaccine production. He that the Indian pharmaceutical industry wants to digitize itself in order to function well and efficiently.
The Indian pharmaceutical industry exports medicines to 206 countries. That number is destined to grow, representing a new trail globally only in drug production, but also in studies and development, Jain said.
Delving into the demanding situations of the pharmaceutical industry, OP Singh, president of sales and marketing for Cadila Pharma, said in a statement: “The reuse of drugs can be a factor in fighting the pandemic and saving people’s lives. . “
Vivek Srivastava, co-founder and CEO of HealthCare at Home, expressed its importance in virtual adoption and its importance in pharmaceutical marketing: “I have noticed the adoption of virtual Covid-19 on a giant scale across the country, including in care home isolation, we use virtual platforms for doctor consultations. Using virtual technology, we treat about 2,500 patients in isolation at home. Digital adoption is booming everywhere, adding to pharmaceutical marketing. “
GS Grewal, president-elect of the DMA, said that in Delhi even 30% of doctors had a desktop computer in the pre-Covid-19 era. Therefore, to promote appropriate virtual adoption, schooling and schooling are essential.
Commenting on the accessibility of medicines in India, Atul Sharma, founder and CEO of HealthScape, said production volumes in India have advanced significantly after falling to 50-60% in April 2020, given the strict blockade. % in May-June 2020, as of April.
“In India, we have been in a pretty smart position in terms of accessibility to medicines because they are easily available without a prescription, compared to Eastern European countries,” he added.
Existing users, log in here
Access Hindu Businessline content on desktops, tablets, and mobile devices.
Get a diverse set of insights from our experts in portfolio, banking, economics, environment, and more.
Discover an ad-free cleaner with faster charging times.
Customize your personal tastes and get personalized advice on your interest.
Existing users, login here
More